{"id":464,"date":"2024-09-12T13:24:36","date_gmt":"2024-09-12T10:24:36","guid":{"rendered":"https:\/\/info.e-med.co.il\/veoza\/?page_id=464"},"modified":"2024-09-16T09:47:11","modified_gmt":"2024-09-16T06:47:11","slug":"veoza-resources","status":"publish","type":"page","link":"https:\/\/info.e-med.co.il\/veoza\/veoza-resources\/","title":{"rendered":"Resources"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"464\" class=\"elementor elementor-464\" data-elementor-post-type=\"page\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-7c5a6dd elementor-section-content-bottom elementor-section-full_width elementor-section-height-default elementor-section-height-default\" data-id=\"7c5a6dd\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t\t<div class=\"elementor-background-overlay\"><\/div>\n\t\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-f515f90\" data-id=\"f515f90\" data-element_type=\"column\" data-e-type=\"column\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-2ef9914 elementor-widget elementor-widget-image\" data-id=\"2ef9914\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t<figure class=\"wp-caption\">\n\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"479\" src=\"https:\/\/info.e-med.co.il\/veoza\/files\/2024\/09\/veoza-hcp-il-en-resources-1024x479.jpg\" class=\"attachment-large size-large wp-image-190\" alt=\"Cool Veoza tools for your practice\" srcset=\"https:\/\/info.e-med.co.il\/veoza\/files\/2024\/09\/veoza-hcp-il-en-resources-1024x479.jpg 1024w, https:\/\/info.e-med.co.il\/veoza\/files\/2024\/09\/veoza-hcp-il-en-resources-300x140.jpg 300w, https:\/\/info.e-med.co.il\/veoza\/files\/2024\/09\/veoza-hcp-il-en-resources-768x359.jpg 768w, https:\/\/info.e-med.co.il\/veoza\/files\/2024\/09\/veoza-hcp-il-en-resources.jpg 1276w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/>\t\t\t\t\t\t\t\t\t\t\t<figcaption class=\"widget-image-caption wp-caption-text\"><\/figcaption>\n\t\t\t\t\t\t\t\t\t\t<\/figure>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-4df2be6 elementor-section-full_width elementor-section-height-default elementor-section-height-default\" data-id=\"4df2be6\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-376e88a\" data-id=\"376e88a\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-93b3f38 elementor-widget elementor-widget-heading\" data-id=\"93b3f38\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h1 class=\"elementor-heading-title elementor-size-default\">Simplify the VMS conversation with easy-to-use VEOZA resources<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-76cca13 elementor-widget elementor-widget-heading\" data-id=\"76cca13\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h5 class=\"elementor-heading-title elementor-size-default\">Download or share resources below\n<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-7c44e49 elementor-section-full_width elementor-section-height-default elementor-section-height-default\" data-id=\"7c44e49\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t\t<div class=\"elementor-background-overlay\"><\/div>\n\t\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-8ea30a1\" data-id=\"8ea30a1\" data-element_type=\"column\" data-e-type=\"column\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-00369d2 elementor-widget__width-initial elementor-widget elementor-widget-heading\" data-id=\"00369d2\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h6 class=\"elementor-heading-title elementor-size-default\">Provider<\/h6>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-141d853 elementor-section-full_width elementor-section-height-default elementor-section-height-default\" data-id=\"141d853\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-8326a64\" data-id=\"8326a64\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-843f809 positive-bt elementor-widget elementor-widget-image\" data-id=\"843f809\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t<figure class=\"wp-caption\">\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/info.e-med.co.il\/protected\/veoza\/Veoza_flashcard.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t<img decoding=\"async\" width=\"800\" height=\"494\" src=\"https:\/\/info.e-med.co.il\/veoza\/files\/2024\/09\/veoza_au_en_resources_card1_image_v1.png\" class=\"attachment-large size-large wp-image-467\" alt=\"\" srcset=\"https:\/\/info.e-med.co.il\/veoza\/files\/2024\/09\/veoza_au_en_resources_card1_image_v1.png 800w, https:\/\/info.e-med.co.il\/veoza\/files\/2024\/09\/veoza_au_en_resources_card1_image_v1-300x185.png 300w, https:\/\/info.e-med.co.il\/veoza\/files\/2024\/09\/veoza_au_en_resources_card1_image_v1-768x474.png 768w\" sizes=\"(max-width: 800px) 100vw, 800px\" \/>\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<figcaption class=\"widget-image-caption wp-caption-text\"><\/figcaption>\n\t\t\t\t\t\t\t\t\t\t<\/figure>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-5b739fb\" data-id=\"5b739fb\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-25ec62c elementor-widget elementor-widget-heading\" data-id=\"25ec62c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Mechanism of action (MOA) flashcard<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-6f72dfd elementor-widget elementor-widget-heading\" data-id=\"6f72dfd\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<p class=\"elementor-heading-title elementor-size-default\">Quickly reference VEOZA in your practice.\n\n<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-de8fb6e elementor-tablet-align-justify elementor-widget elementor-widget-button\" data-id=\"de8fb6e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-lg\" href=\"https:\/\/info.e-med.co.il\/protected\/veoza\/Veoza_flashcard.pdf\" target=\"_blank\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Download<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-132abb4 elementor-section-full_width elementor-section-height-default elementor-section-height-default\" data-id=\"132abb4\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-83a0c31\" data-id=\"83a0c31\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-c045210 elementor-widget elementor-widget-video\" data-id=\"c045210\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;video_type&quot;:&quot;vimeo&quot;}\" data-widget_type=\"video.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-wrapper elementor-open-inline\">\n\t\t\t<div class=\"embed\"><iframe class=\"elementor-video-iframe\" allowfullscreen allow=\"clipboard-write\" title=\"vimeo Video Player\" src=\"https:\/\/player.vimeo.com\/video\/994734185?color&amp;autopause=0&amp;loop=0&amp;muted=0&amp;title=1&amp;portrait=1&amp;byline=1#t=\"><\/iframe><\/div>\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-850707b\" data-id=\"850707b\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-4375f83 elementor-widget elementor-widget-heading\" data-id=\"4375f83\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">MOA video<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-278ab1c elementor-widget elementor-widget-heading\" data-id=\"278ab1c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<p class=\"elementor-heading-title elementor-size-default\">Watch the mechanism of action of VEOZA.\n\n\n<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-0e65ba8 elementor-tablet-align-justify positive-bt elementor-widget elementor-widget-button\" data-id=\"0e65ba8\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-lg\" href=\"#elementor-action%3Aaction%3Dpopup%3Aopen%26settings%3DeyJpZCI6IjM4MiIsInRvZ2dsZSI6ZmFsc2V9\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">See the video<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-2315c50 elementor-section-full_width elementor-section-height-default elementor-section-height-default\" data-id=\"2315c50\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-f4a0ca7\" data-id=\"f4a0ca7\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-cbbcbd8 elementor-widget elementor-widget-heading\" data-id=\"cbbcbd8\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Frequently asked questions<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-e246cb4 elementor-widget elementor-widget-toggle\" data-id=\"e246cb4\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"toggle.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-toggle\">\n\t\t\t\t\t\t\t<div class=\"elementor-toggle-item\">\n\t\t\t\t\t<div id=\"elementor-tab-title-2371\" class=\"elementor-tab-title\" data-tab=\"1\" role=\"button\" aria-controls=\"elementor-tab-content-2371\" aria-expanded=\"false\">\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon elementor-toggle-icon-right\" aria-hidden=\"true\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-closed\"><i class=\"fas fa-plus-circle\"><\/i><\/span>\n\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-opened\"><i class=\"elementor-toggle-icon-opened fas fa-minus-circle\"><\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t<a class=\"elementor-toggle-title\" tabindex=\"0\">What is VEOZA?<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t<div id=\"elementor-tab-content-2371\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"1\" role=\"region\" aria-labelledby=\"elementor-tab-title-2371\"><div id=\"accordion-ee5f595aec-item-253b4f8c8a\" class=\"cmp-accordion__item\" data-cmp-hook-accordion=\"item\" data-cmp-data-layer=\"{&quot;accordion-ee5f595aec-item-253b4f8c8a&quot;:{&quot;@type&quot;:&quot;global\/components\/globalcomponents\/accordion\/v1.1\/accordion\/item&quot;,&quot;dc:title&quot;:&quot;What is VEOZA?&quot;}}\" data-cmp-expanded=\"\"><div id=\"accordion-ee5f595aec-item-253b4f8c8a-panel\" class=\"cmp-accordion__panel cmp-accordion__panel--expanded\" role=\"region\" data-cmp-hook-accordion=\"panel\" aria-labelledby=\"accordion-ee5f595aec-item-253b4f8c8a-button\" aria-hidden=\"false\"><div class=\"container responsivegrid\"><div id=\"container-253b4f8c8a\" class=\"cmp-container\"><div class=\"text bold-styling step-0\"><div id=\"text-6f7d0947d4\" class=\"cmp-text\" style=\"box-sizing: inherit; font-size: var(--step-0);\" data-cmp-data-layer=\"{&quot;text-6f7d0947d4&quot;:{&quot;@type&quot;:&quot;global\/components\/globalcomponents\/text\/v1\/text&quot;,&quot;repo:modifyDate&quot;:&quot;2024-01-17T17:45:26Z&quot;,&quot;xdm:text&quot;:&quot;&lt;p&gt;VEOZA is a neurokinin 3 (NK3) receptor antagonist for the treatment of moderate to severe Vasomotor Symptoms (VMS) associated with menopause, also known as hot flushes and night sweats.&lt;sup&gt;1,2&lt;\/sup&gt;&lt;\/p&gt;\\r\\n&quot;}}\"><p>VEOZA is a neurokinin 3 (NK3) receptor antagonist for the treatment of moderate to severe Vasomotor Symptoms (VMS) associated with menopause, also known as hot flushes and night sweats.<sup>1,2<\/sup><\/p><\/div><\/div><\/div><\/div><\/div><\/div><div id=\"accordion-ee5f595aec-item-9663f87621\" class=\"cmp-accordion__item\" data-cmp-hook-accordion=\"item\" data-cmp-data-layer=\"{&quot;accordion-ee5f595aec-item-9663f87621&quot;:{&quot;@type&quot;:&quot;global\/components\/globalcomponents\/accordion\/v1.1\/accordion\/item&quot;,&quot;dc:title&quot;:&quot;How does VEOZA work? &quot;}}\"><div class=\"text\"><div id=\"text-ebbc3186d0\" class=\"cmp-text\" style=\"box-sizing: inherit;\" data-cmp-data-layer=\"{&quot;text-ebbc3186d0&quot;:{&quot;@type&quot;:&quot;global\/components\/globalcomponents\/text\/v1\/text&quot;,&quot;repo:modifyDate&quot;:&quot;2023-12-05T13:34:40Z&quot;,&quot;xdm:text&quot;:&quot;&lt;p&gt;How does VEOZA work? &lt;\/p&gt;\\r\\n&quot;}}\">\u00a0<\/div><\/div><\/div><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"elementor-toggle-item\">\n\t\t\t\t\t<div id=\"elementor-tab-title-2372\" class=\"elementor-tab-title\" data-tab=\"2\" role=\"button\" aria-controls=\"elementor-tab-content-2372\" aria-expanded=\"false\">\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon elementor-toggle-icon-right\" aria-hidden=\"true\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-closed\"><i class=\"fas fa-plus-circle\"><\/i><\/span>\n\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-opened\"><i class=\"elementor-toggle-icon-opened fas fa-minus-circle\"><\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t<a class=\"elementor-toggle-title\" tabindex=\"0\">How does VEOZA work?<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t<div id=\"elementor-tab-content-2372\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"2\" role=\"region\" aria-labelledby=\"elementor-tab-title-2372\">VEOZA is not a hormone. It is a\u00a0<a href=\"\/veoza\/mechanism-of-action#veoza-hormone\" target=\"_self\">VMS treatment<\/a>\u00a0that directly blocks NKB binding, a known trigger of VMS associated with menopause.<sup>1,3,4<\/sup>\n\nIt is a selective NK3 receptor antagonist that blocks NKB binding on the KNDy neuron to modulate neuronal activity in the temperature control centre. This action helps to reduce the number and intensity of hot flushes and night sweats.<sup>1<\/sup>\n<p style=\"font-size: 90%;\">KNDy: kisspeptin\/neurokinin B\/dynorphin, NK3: neurokinin 3, NKB: neurokinin B.<\/p>\n<p><a class=\"button\" title=\"Mechanism of Action\" role=\"button\" href=\"https:\/\/info.e-med.co.il\/veoza\/mechanism-of-action\/#MOA\">WATCH THE MOA VIDEO<\/a><\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"elementor-toggle-item\">\n\t\t\t\t\t<div id=\"elementor-tab-title-2373\" class=\"elementor-tab-title\" data-tab=\"3\" role=\"button\" aria-controls=\"elementor-tab-content-2373\" aria-expanded=\"false\">\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon elementor-toggle-icon-right\" aria-hidden=\"true\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-closed\"><i class=\"fas fa-plus-circle\"><\/i><\/span>\n\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-opened\"><i class=\"elementor-toggle-icon-opened fas fa-minus-circle\"><\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t<a class=\"elementor-toggle-title\" tabindex=\"0\">What are the coprimary efficacy endpoint results from VEOZA clinical trials?<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t<div id=\"elementor-tab-content-2373\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"3\" role=\"region\" aria-labelledby=\"elementor-tab-title-2373\"><a style=\"box-sizing: inherit; letter-spacing: 0px;\" href=\"\/veoza\/efficacy-and-safety\/\" target=\"_self\">VEOZA demonstrated statistically significant reductions<\/a>\u00a0from baseline in the frequency and severity of moderate to severe VMS over 24 hours compared to placebo, at weeks 4 and 12.<sup>1*<\/sup>\n\nThe efficacy of VEOZA was evaluated in two 12-week, randomised, placebo-controlled, double-blind Phase 3 studies, followed by a 40-week extension treatment period.<sup>1<\/sup>\n<p style=\"font-size: 90%;\">*Statistically significantly superior compared to placebo at the 0.05 level with multiplicity adjustment.<sup>1<\/sup><\/p>\n<p><a class=\"button\" title=\"SEE THE FULL STUDY RESULTS\" role=\"button\" href=\"\/veoza\/efficacy-and-safety\/\">SEE THE FULL STUDY RESULTS<\/a><\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"elementor-toggle-item\">\n\t\t\t\t\t<div id=\"elementor-tab-title-2374\" class=\"elementor-tab-title\" data-tab=\"4\" role=\"button\" aria-controls=\"elementor-tab-content-2374\" aria-expanded=\"false\">\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon elementor-toggle-icon-right\" aria-hidden=\"true\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-closed\"><i class=\"fas fa-plus-circle\"><\/i><\/span>\n\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-opened\"><i class=\"elementor-toggle-icon-opened fas fa-minus-circle\"><\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t<a class=\"elementor-toggle-title\" tabindex=\"0\">How is VEOZA administered?<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t<div id=\"elementor-tab-content-2374\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"4\" role=\"region\" aria-labelledby=\"elementor-tab-title-2374\"><p>VEOZA 45 mg should be taken orally once daily with liquids, with or without food. VEOZA should be swallowed whole. Do not cut, crush, or chew tablets. Patients can choose what time to take it, but should adhere to the same time each day.<sup>1<\/sup><\/p><p>\u00a0<\/p><p><a class=\"button\" title=\"SEE DOSING\" role=\"button\" href=\"\/veoza\/dosing\">SEE DOSING<\/a><\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"elementor-toggle-item\">\n\t\t\t\t\t<div id=\"elementor-tab-title-2375\" class=\"elementor-tab-title\" data-tab=\"5\" role=\"button\" aria-controls=\"elementor-tab-content-2375\" aria-expanded=\"false\">\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon elementor-toggle-icon-right\" aria-hidden=\"true\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-closed\"><i class=\"fas fa-plus-circle\"><\/i><\/span>\n\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-opened\"><i class=\"elementor-toggle-icon-opened fas fa-minus-circle\"><\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t<a class=\"elementor-toggle-title\" tabindex=\"0\">What are the potential side effects of VEOZA?<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t<div id=\"elementor-tab-content-2375\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"5\" role=\"region\" aria-labelledby=\"elementor-tab-title-2375\"><p>Across the Phase 3 studies, the most common adverse reactions (\u22653%) with VEOZA 45 mg were diarrhoea (3.2%) and insomnia (3.0%). The most frequent adverse reactions leading to dose discontinuation with VEOZA were alanine aminotransferase (ALT) increased (0.3%) and insomnia (0.2%).<\/p><p><a class=\"button\" title=\"EXPLORE THE SAFETY OF VEOZA\" role=\"button\" href=\"\/veoza\/efficacy-and-safety\">EXPLORE THE SAFETY OF VEOZA<\/a><\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"elementor-toggle-item\">\n\t\t\t\t\t<div id=\"elementor-tab-title-2376\" class=\"elementor-tab-title\" data-tab=\"6\" role=\"button\" aria-controls=\"elementor-tab-content-2376\" aria-expanded=\"false\">\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon elementor-toggle-icon-right\" aria-hidden=\"true\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-closed\"><i class=\"fas fa-plus-circle\"><\/i><\/span>\n\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-opened\"><i class=\"elementor-toggle-icon-opened fas fa-minus-circle\"><\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t<a class=\"elementor-toggle-title\" tabindex=\"0\">What resources are available for my practice?<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t<div id=\"elementor-tab-content-2376\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"6\" role=\"region\" aria-labelledby=\"elementor-tab-title-2376\"><p><u><a title=\"Resources\" href=\"https:\/\/info.e-med.co.il\/veoza\/veoza-resources\/\">Practice resources<\/a><\/u>\u00a0are available to help you quickly reference VEOZA.<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t<script type=\"application\/ld+json\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What is VEOZA?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"<div id=\\\"accordion-ee5f595aec-item-253b4f8c8a\\\" class=\\\"cmp-accordion__item\\\" data-cmp-hook-accordion=\\\"item\\\" data-cmp-data-layer=\\\"{&quot;accordion-ee5f595aec-item-253b4f8c8a&quot;:{&quot;@type&quot;:&quot;global\\\/components\\\/globalcomponents\\\/accordion\\\/v1.1\\\/accordion\\\/item&quot;,&quot;dc:title&quot;:&quot;What is VEOZA?&quot;}}\\\" data-cmp-expanded=\\\"\\\"><div id=\\\"accordion-ee5f595aec-item-253b4f8c8a-panel\\\" class=\\\"cmp-accordion__panel cmp-accordion__panel--expanded\\\" role=\\\"region\\\" data-cmp-hook-accordion=\\\"panel\\\" aria-labelledby=\\\"accordion-ee5f595aec-item-253b4f8c8a-button\\\" aria-hidden=\\\"false\\\"><div class=\\\"container responsivegrid\\\"><div id=\\\"container-253b4f8c8a\\\" class=\\\"cmp-container\\\"><div class=\\\"text bold-styling step-0\\\"><div id=\\\"text-6f7d0947d4\\\" class=\\\"cmp-text\\\" style=\\\"box-sizing: inherit; font-size: var(--step-0);\\\" data-cmp-data-layer=\\\"{&quot;text-6f7d0947d4&quot;:{&quot;@type&quot;:&quot;global\\\/components\\\/globalcomponents\\\/text\\\/v1\\\/text&quot;,&quot;repo:modifyDate&quot;:&quot;2024-01-17T17:45:26Z&quot;,&quot;xdm:text&quot;:&quot;&lt;p&gt;VEOZA is a neurokinin 3 (NK3) receptor antagonist for the treatment of moderate to severe Vasomotor Symptoms (VMS) associated with menopause, also known as hot flushes and night sweats.&lt;sup&gt;1,2&lt;\\\/sup&gt;&lt;\\\/p&gt;\\\\r\\\\n&quot;}}\\\"><p>VEOZA is a neurokinin 3 (NK3) receptor antagonist for the treatment of moderate to severe Vasomotor Symptoms (VMS) associated with menopause, also known as hot flushes and night sweats.<sup>1,2<\\\/sup><\\\/p><\\\/div><\\\/div><\\\/div><\\\/div><\\\/div><\\\/div><div id=\\\"accordion-ee5f595aec-item-9663f87621\\\" class=\\\"cmp-accordion__item\\\" data-cmp-hook-accordion=\\\"item\\\" data-cmp-data-layer=\\\"{&quot;accordion-ee5f595aec-item-9663f87621&quot;:{&quot;@type&quot;:&quot;global\\\/components\\\/globalcomponents\\\/accordion\\\/v1.1\\\/accordion\\\/item&quot;,&quot;dc:title&quot;:&quot;How does VEOZA work? &quot;}}\\\"><div class=\\\"text\\\"><div id=\\\"text-ebbc3186d0\\\" class=\\\"cmp-text\\\" style=\\\"box-sizing: inherit;\\\" data-cmp-data-layer=\\\"{&quot;text-ebbc3186d0&quot;:{&quot;@type&quot;:&quot;global\\\/components\\\/globalcomponents\\\/text\\\/v1\\\/text&quot;,&quot;repo:modifyDate&quot;:&quot;2023-12-05T13:34:40Z&quot;,&quot;xdm:text&quot;:&quot;&lt;p&gt;How does VEOZA work? &lt;\\\/p&gt;\\\\r\\\\n&quot;}}\\\">\\u00a0<\\\/div><\\\/div><\\\/div>\"}},{\"@type\":\"Question\",\"name\":\"How does VEOZA work?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"VEOZA is not a hormone. It is a\\u00a0<a href=\\\"\\\/veoza\\\/mechanism-of-action#veoza-hormone\\\" target=\\\"_self\\\">VMS treatment<\\\/a>\\u00a0that directly blocks NKB binding, a known trigger of VMS associated with menopause.<sup>1,3,4<\\\/sup>\\n\\nIt is a selective NK3 receptor antagonist that blocks NKB binding on the KNDy neuron to modulate neuronal activity in the temperature control centre. This action helps to reduce the number and intensity of hot flushes and night sweats.<sup>1<\\\/sup>\\n<p style=\\\"font-size: 90%;\\\">KNDy: kisspeptin\\\/neurokinin B\\\/dynorphin, NK3: neurokinin 3, NKB: neurokinin B.<\\\/p>\\n<p><a class=\\\"button\\\" title=\\\"Mechanism of Action\\\" role=\\\"button\\\" href=\\\"https:\\\/\\\/info.e-med.co.il\\\/veoza\\\/mechanism-of-action\\\/#MOA\\\">WATCH THE MOA VIDEO<\\\/a><\\\/p>\"}},{\"@type\":\"Question\",\"name\":\"What are the coprimary efficacy endpoint results from VEOZA clinical trials?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"<a style=\\\"box-sizing: inherit; letter-spacing: 0px;\\\" href=\\\"\\\/veoza\\\/efficacy-and-safety\\\/\\\" target=\\\"_self\\\">VEOZA demonstrated statistically significant reductions<\\\/a>\\u00a0from baseline in the frequency and severity of moderate to severe VMS over 24 hours compared to placebo, at weeks 4 and 12.<sup>1*<\\\/sup>\\n\\nThe efficacy of VEOZA was evaluated in two 12-week, randomised, placebo-controlled, double-blind Phase 3 studies, followed by a 40-week extension treatment period.<sup>1<\\\/sup>\\n<p style=\\\"font-size: 90%;\\\">*Statistically significantly superior compared to placebo at the 0.05 level with multiplicity adjustment.<sup>1<\\\/sup><\\\/p>\\n<p><a class=\\\"button\\\" title=\\\"SEE THE FULL STUDY RESULTS\\\" role=\\\"button\\\" href=\\\"\\\/veoza\\\/efficacy-and-safety\\\/\\\">SEE THE FULL STUDY RESULTS<\\\/a><\\\/p>\"}},{\"@type\":\"Question\",\"name\":\"How is VEOZA administered?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"<p>VEOZA 45 mg should be taken orally once daily with liquids, with or without food. VEOZA should be swallowed whole. Do not cut, crush, or chew tablets. Patients can choose what time to take it, but should adhere to the same time each day.<sup>1<\\\/sup><\\\/p><p>\\u00a0<\\\/p><p><a class=\\\"button\\\" title=\\\"SEE DOSING\\\" role=\\\"button\\\" href=\\\"\\\/veoza\\\/dosing\\\">SEE DOSING<\\\/a><\\\/p>\"}},{\"@type\":\"Question\",\"name\":\"What are the potential side effects of VEOZA?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"<p>Across the Phase 3 studies, the most common adverse reactions (\\u22653%) with VEOZA 45 mg were diarrhoea (3.2%) and insomnia (3.0%). The most frequent adverse reactions leading to dose discontinuation with VEOZA were alanine aminotransferase (ALT) increased (0.3%) and insomnia (0.2%).<\\\/p><p><a class=\\\"button\\\" title=\\\"EXPLORE THE SAFETY OF VEOZA\\\" role=\\\"button\\\" href=\\\"\\\/veoza\\\/efficacy-and-safety\\\">EXPLORE THE SAFETY OF VEOZA<\\\/a><\\\/p>\"}},{\"@type\":\"Question\",\"name\":\"What resources are available for my practice?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"<p><u><a title=\\\"Resources\\\" href=\\\"https:\\\/\\\/info.e-med.co.il\\\/veoza\\\/veoza-resources\\\/\\\">Practice resources<\\\/a><\\\/u>\\u00a0are available to help you quickly reference VEOZA.<\\\/p>\"}}]}<\/script>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-36ba715 elementor-section-full_width elementor-section-height-default elementor-section-height-default\" data-id=\"36ba715\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-d28e349\" data-id=\"d28e349\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-6890e32 elementor-widget elementor-widget-text-editor\" data-id=\"6890e32\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><b>REFERENCES<\/b>:\u00a0<b>1<\/b>. VEOZA\u00a0<a href=\"\/veoza\/files\/2024\/09\/veoza-fezolinetant-smpc.pdf\" target=\"_blank\" rel=\"noopener\">[Veoza Israeli SmPC]<\/a>\u00a0<b>2<\/b>. Thurston RC. Vasomotor symptoms. In: Crandall CJ, Bachman GA, Faubion SS, et al., eds. Menopause Practice: A Clinician\u2019s Guide. 6th ed. Pepper Pike, OH: The North American Menopause Society, 2019:43-55.\u00a0<b>3.<\/b>\u00a0Depypere H, Lademacher C, Siddiqui E, Fraser GL. Fezolinetant in the treatment of vasomotor symptoms associated with menopause. Expert Opin Investig Drugs 2021;30(7):681-94.<b>\u00a04.<\/b>\u00a0Jayasena CN, Comninos AN, Stefanopoulou E, et al. Neurokinin B administration induces hot flushes in women. Sci Rep (Epub) 02-16-2015.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Simplify the VMS conversation with easy-to-use VEOZA resources Download or share resources below Provider Mechanism of action (MOA) flashcard Quickly reference VEOZA in your practice. Download MOA video Watch the mechanism of action of VEOZA. See the video Frequently asked questions What is VEOZA? VEOZA is a neurokinin 3 (NK3) receptor antagonist for the treatment [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"open","template":"","meta":{"footnotes":""},"class_list":["post-464","page","type-page","status-publish","hentry"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 4.9.8 - aioseo.com -->\n\t<meta name=\"description\" content=\"Simplify the VMS conversation with easy-to-use VEOZA resources Download or share resources below Provider Mechanism of action (MOA) flashcard Quickly reference VEOZA in your practice. Download MOA video Watch the mechanism of action of VEOZA. See the video Frequently asked questions What is VEOZA? VEOZA is a neurokinin 3 (NK3) receptor antagonist for the treatment\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<link rel=\"canonical\" href=\"https:\/\/info.e-med.co.il\/veoza\/veoza-resources\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 4.9.8\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_GB\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Veoza - VEOZA is indicated for the treatment of moderate to severe Vasomotor Symptoms (VMS) associated with menopause\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Resources - Veoza\" \/>\n\t\t<meta property=\"og:description\" content=\"Simplify the VMS conversation with easy-to-use VEOZA resources Download or share resources below Provider Mechanism of action (MOA) flashcard Quickly reference VEOZA in your practice. Download MOA video Watch the mechanism of action of VEOZA. See the video Frequently asked questions What is VEOZA? VEOZA is a neurokinin 3 (NK3) receptor antagonist for the treatment\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/info.e-med.co.il\/veoza\/veoza-resources\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2024-09-12T10:24:36+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2024-09-16T06:47:11+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Resources - Veoza\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Simplify the VMS conversation with easy-to-use VEOZA resources Download or share resources below Provider Mechanism of action (MOA) flashcard Quickly reference VEOZA in your practice. Download MOA video Watch the mechanism of action of VEOZA. See the video Frequently asked questions What is VEOZA? VEOZA is a neurokinin 3 (NK3) receptor antagonist for the treatment\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/veoza\\\/veoza-resources\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/veoza#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/info.e-med.co.il\\\/veoza\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/veoza\\\/veoza-resources\\\/#listItem\",\"name\":\"Resources\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/veoza\\\/veoza-resources\\\/#listItem\",\"position\":2,\"name\":\"Resources\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/veoza#listItem\",\"name\":\"Home\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/veoza\\\/#organization\",\"name\":\"Veoza\",\"description\":\"VEOZA is indicated for the treatment of moderate to severe Vasomotor Symptoms (VMS) associated with menopause\",\"url\":\"https:\\\/\\\/info.e-med.co.il\\\/veoza\\\/\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/veoza\\\/veoza-resources\\\/#webpage\",\"url\":\"https:\\\/\\\/info.e-med.co.il\\\/veoza\\\/veoza-resources\\\/\",\"name\":\"Resources - Veoza\",\"description\":\"Simplify the VMS conversation with easy-to-use VEOZA resources Download or share resources below Provider Mechanism of action (MOA) flashcard Quickly reference VEOZA in your practice. Download MOA video Watch the mechanism of action of VEOZA. See the video Frequently asked questions What is VEOZA? VEOZA is a neurokinin 3 (NK3) receptor antagonist for the treatment\",\"inLanguage\":\"en-GB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/veoza\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/veoza\\\/veoza-resources\\\/#breadcrumblist\"},\"datePublished\":\"2024-09-12T13:24:36+03:00\",\"dateModified\":\"2024-09-16T09:47:11+03:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/veoza\\\/#website\",\"url\":\"https:\\\/\\\/info.e-med.co.il\\\/veoza\\\/\",\"name\":\"Veoza\",\"description\":\"VEOZA is indicated for the treatment of moderate to severe Vasomotor Symptoms (VMS) associated with menopause\",\"inLanguage\":\"en-GB\",\"publisher\":{\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/veoza\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Resources - Veoza","description":"Simplify the VMS conversation with easy-to-use VEOZA resources Download or share resources below Provider Mechanism of action (MOA) flashcard Quickly reference VEOZA in your practice. Download MOA video Watch the mechanism of action of VEOZA. See the video Frequently asked questions What is VEOZA? VEOZA is a neurokinin 3 (NK3) receptor antagonist for the treatment","canonical_url":"https:\/\/info.e-med.co.il\/veoza\/veoza-resources\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/info.e-med.co.il\/veoza\/veoza-resources\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/info.e-med.co.il\/veoza#listItem","position":1,"name":"Home","item":"https:\/\/info.e-med.co.il\/veoza","nextItem":{"@type":"ListItem","@id":"https:\/\/info.e-med.co.il\/veoza\/veoza-resources\/#listItem","name":"Resources"}},{"@type":"ListItem","@id":"https:\/\/info.e-med.co.il\/veoza\/veoza-resources\/#listItem","position":2,"name":"Resources","previousItem":{"@type":"ListItem","@id":"https:\/\/info.e-med.co.il\/veoza#listItem","name":"Home"}}]},{"@type":"Organization","@id":"https:\/\/info.e-med.co.il\/veoza\/#organization","name":"Veoza","description":"VEOZA is indicated for the treatment of moderate to severe Vasomotor Symptoms (VMS) associated with menopause","url":"https:\/\/info.e-med.co.il\/veoza\/"},{"@type":"WebPage","@id":"https:\/\/info.e-med.co.il\/veoza\/veoza-resources\/#webpage","url":"https:\/\/info.e-med.co.il\/veoza\/veoza-resources\/","name":"Resources - Veoza","description":"Simplify the VMS conversation with easy-to-use VEOZA resources Download or share resources below Provider Mechanism of action (MOA) flashcard Quickly reference VEOZA in your practice. Download MOA video Watch the mechanism of action of VEOZA. See the video Frequently asked questions What is VEOZA? VEOZA is a neurokinin 3 (NK3) receptor antagonist for the treatment","inLanguage":"en-GB","isPartOf":{"@id":"https:\/\/info.e-med.co.il\/veoza\/#website"},"breadcrumb":{"@id":"https:\/\/info.e-med.co.il\/veoza\/veoza-resources\/#breadcrumblist"},"datePublished":"2024-09-12T13:24:36+03:00","dateModified":"2024-09-16T09:47:11+03:00"},{"@type":"WebSite","@id":"https:\/\/info.e-med.co.il\/veoza\/#website","url":"https:\/\/info.e-med.co.il\/veoza\/","name":"Veoza","description":"VEOZA is indicated for the treatment of moderate to severe Vasomotor Symptoms (VMS) associated with menopause","inLanguage":"en-GB","publisher":{"@id":"https:\/\/info.e-med.co.il\/veoza\/#organization"}}]},"og:locale":"en_GB","og:site_name":"Veoza - VEOZA is indicated for the treatment of moderate to severe Vasomotor Symptoms (VMS) associated with menopause","og:type":"article","og:title":"Resources - Veoza","og:description":"Simplify the VMS conversation with easy-to-use VEOZA resources Download or share resources below Provider Mechanism of action (MOA) flashcard Quickly reference VEOZA in your practice. Download MOA video Watch the mechanism of action of VEOZA. See the video Frequently asked questions What is VEOZA? VEOZA is a neurokinin 3 (NK3) receptor antagonist for the treatment","og:url":"https:\/\/info.e-med.co.il\/veoza\/veoza-resources\/","article:published_time":"2024-09-12T10:24:36+00:00","article:modified_time":"2024-09-16T06:47:11+00:00","twitter:card":"summary_large_image","twitter:title":"Resources - Veoza","twitter:description":"Simplify the VMS conversation with easy-to-use VEOZA resources Download or share resources below Provider Mechanism of action (MOA) flashcard Quickly reference VEOZA in your practice. Download MOA video Watch the mechanism of action of VEOZA. See the video Frequently asked questions What is VEOZA? VEOZA is a neurokinin 3 (NK3) receptor antagonist for the treatment"},"aioseo_meta_data":{"post_id":"464","title":null,"description":null,"keywords":[],"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":[],"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"WebPage","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2024-09-12 10:24:13","updated":"2025-08-06 07:07:04","seo_analyzer_scan_date":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/info.e-med.co.il\/veoza\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tResources\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/info.e-med.co.il\/veoza"},{"label":"Resources","link":"https:\/\/info.e-med.co.il\/veoza\/veoza-resources\/"}],"_links":{"self":[{"href":"https:\/\/info.e-med.co.il\/veoza\/wp-json\/wp\/v2\/pages\/464","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/info.e-med.co.il\/veoza\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/info.e-med.co.il\/veoza\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/info.e-med.co.il\/veoza\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/info.e-med.co.il\/veoza\/wp-json\/wp\/v2\/comments?post=464"}],"version-history":[{"count":52,"href":"https:\/\/info.e-med.co.il\/veoza\/wp-json\/wp\/v2\/pages\/464\/revisions"}],"predecessor-version":[{"id":596,"href":"https:\/\/info.e-med.co.il\/veoza\/wp-json\/wp\/v2\/pages\/464\/revisions\/596"}],"wp:attachment":[{"href":"https:\/\/info.e-med.co.il\/veoza\/wp-json\/wp\/v2\/media?parent=464"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}